Company · CIK 2028614
Drugs Made In America Acquisition Corp.
| CIK | 2028614 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 6770 — Blank Checks |
| Business address | NY |
| Listed | DMAA (Nasdaq), DMAAR (Nasdaq), DMAAU (Nasdaq) |
| First annual or quarterly report | 2025-03-31 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-281170 | 2024-08-01 | 2025-01-29 | 10 |
Filings
10| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-01-29 | 424B4Final prospectus | 333-281170 | 0001213900-25-007724 |
| 2025-01-27 | EFFECTDeclared effective | 333-281170 | 9999999995-25-000196 |
| 2025-01-07 | EFFECTDeclared effective | 333-281170 | 9999999995-25-000044 |
| 2025-01-06 | S-1/AAmendment | 333-281170 | 0001213900-25-001208 |
| 2024-12-09 | S-1/AAmendment | 333-281170 | 0001213900-24-106894 |
| 2024-11-25 | S-1/AAmendment | 333-281170 | 0001213900-24-102238 |
| 2024-11-07 | S-1/AAmendment | 333-281170 | 0001213900-24-095138 |
| 2024-09-27 | S-1/AAmendment | 333-281170 | 0001213900-24-082386 |
| 2024-09-06 | S-1/AAmendment | 333-281170 | 0001213900-24-076546 |
| 2024-08-01 | S-1Registration filed | 333-281170 | 0001213900-24-064074 |